Compare Mutual Funds
Up to 4 funds, side-by-side. Best value in each row is highlighted in emerald with a ⭐.
Building your comparison…
| Field | Nippon India Pharma Fund Growth Plan - Bonus Option Nippon India Mutual Fund |
|---|---|
| Fund overview | |
| OnePaisa Score | 4.5/10 · Below Average |
| Fund house | Nippon India Mutual Fund |
| Category | Equity Scheme - Sectoral/ Thematic · sectoral |
| Type | Open Ended Schemes |
| Plan | Direct |
| Launch date | Jan 2013 |
| Performance returns | |
| 1Y return | +1.67% |
| 3Y return (CAGR) | +22.93% |
| 5Y return (CAGR) | +14.20% |
| 10Y return (CAGR) | +15.26% |
| Benchmark | BSE Healthcare TR INR |
| Category avg 1Y | +6.14% |
| SIP returns | |
| SIP 1Y | +1.45% |
| Risk metrics | |
| Volatility (Std Dev 1Y) | 12.05% |
| Sharpe ratio (1Y) | -0.40 |
| Sharpe ratio (3Y) | 1.36 |
| Sortino ratio (1Y) | -0.39 |
| Max drawdown (1Y) | -9.83% |
| Category rank (1Y) | #17 of 25 |
| Quartile (1Y) | Q3 |
| Costs | |
| Expense ratio | 0.92% |
| Portfolio | |
| NAV | ₹591.14 |
| Min SIP | ₹500 |
| Min lump sum | ₹5,000 |
| Tax & redemption | |
| Tax treatment | STCG 20% · LTCG 12.5% above ₹1.25L |
| Lock-in period | None |